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Purpose: This study was performed to quantitatively evaluate the prevalence and risk factors of cataracts 
in Korean patients with type 2 diabetes mellitus. 
Methods: Eight hundred fifty patients (males: 342, mean age: 58.07±8.60 years) with diabetes who 
underwent ophthalmologic evaluation were studied retrospectively. Diabetic patients were classified into a 
cataract group and control group (i.e. a group without cataracts). Risk factors like sex, age, duration of 
diabetes, fasting blood sugar, HbA1c, BUN, creatinine, and total cholesterol were compared between patients 
with and without cataracts. 
Results: Four hundred twenty-five patients (50.00%) had cataracts at evaluation. Females were more 
common in the cataract group than the control group. The mean age did not differ between the two groups. 
Total cholesterol, triglyceride, and LDL cholesterol levels were not different between the two groups. Duration 
of diabetes was significantly longer in patients in the cataract group than in the control group (13.03±6.96 
years vs. 7.03±6.04 years, p<0.001). The patients in the cataract group also had higher levels of HbA1c, 
BUN, creatinine, and fasting blood sugar than those in the control group. Multiple regression analysis 
revealed that the duration of diabetes (p<0.001) was significantly correlated with the presence of cataracts.
Conclusions: The duration of diabetes was the most significant risk factor for cataracts in patients with 
diabetes. This finding indicates that the accumulated effect of hyperglycemia is related to lens transparency 
in patients with diabetes.  Korean Journal of Ophthalmology 20(4):201-204, 2006
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Diabetes mellitus has been reported as the most critical 
factor causing visual loss. Among the various complications 
of diabetes mellitus in the eyes, diabetic retinopathy has been 
regarded as the most common cause of visual loss.
1-3 
Diabetes mellitus is also known as an important risk factor 
for cataracts. In epidemiologic studies published in European 
countries, factors such as a long duration of diabetic disease, 
advanced age at the time of clinical diagnosis, advanced 
retinopathy, treatment with diuretics, and poor control of 
blood sugar level are reported as risk factors for cataract in 
diabetics.
4-11 
However, reports about the prevalence and risk factors of 
cataract in diabetes are limited for Korean patients.
12 Most 
diabetes mellitus cases in Korea are type 2, with a shorter 
duration than in European countries. The incidence and 
prevalence of type 1 diabetes mellitus and juvenile-onset 
diabetes mellitus is lower in Korea than that of European 
populations.
13 Accordingly, it is expected that the incidence 
and risk factors for cataracts in diabetes mellitus are different. 
Furthermore, recent studies have reported that various 
complications such as cardiovascular, nephrologic, and 
ophthalmologic diseases could be prevented by controlling 
glucose in diabetic patients. Therefore, we conducted research 
on the frequency and risk factors of cataracts in Korean 
patients with diabetes. 
From January 2004 to December 2005, 850 patients with 
type 2 diabetes mellitus of the Diabetes Center of Eulji 
Medical Center at Eulji Medical University were evaluated 
retrospectively. All patients underwent an ophthalmologic 
evaluation including slit lamp biomicroscopy and indirect 
ophthalmoscope fundus examination. Three hundred and 
forty-two patients (40.2%) were male and the mean age of 
all patients was 50.87±8.60 years.
A diabetic patient was defined as one who had a serum 
glucose concentration of more than 120 mg/dl while fasting 
more than twice or who had greater than 200 mg/dl when 
measured within two hours after a meal more than twice. The 
diabetic period was defined from the diagnosis of diabetes 
mellitus to the day of the indirect ophthalmoscope fundus 
examination. The fasting serum glucose concentration used in Korean  J  Ophthalmol  Vol.20,  No.4,  2006
202
Total
(N=850)
With  Cataract
(N=425)
Without  Cataract
(N=425) P-value
Male : Female
Age  (years)
Duration
Visual  acuitiy
DMR  (N,  %)*
342 : 508
58.07±8.60
10.03±7.17
 0 . 6 9 ±0.27
480  (56.47%)
155 : 270
58.41±7.89
13.03±6.96
 0 . 5 8 ±0.27
321  (75.53%)
187 : 238
57.72±9.25
 7 . 0 3 ±6.04
 0 . 7 9 ±0.22
159  (37.41%)
0.025
0.238
0.000
0.000
0.000
*DMR:  diabetic  retinopathy.
Table 1. Clinical  characteristics  of  subject  studied
this analysis was the one examined closest to the day of the 
fundus examination. In addition, we investigated HbA1c, total 
cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, 
BUN, and creatinine. Each patient underwent best-corrected 
distance visual acuity measurement with a Snellen chart. 
Visual acuity was defined as the average value of the 
corrected visual acuity of both eyes before examination. An 
ophthalmic examination was performed with slit lamp 
biomicroscopy and indirect ophthalmoscope fundus examina-
tion after the pupil was maximally dilated with 1.0% tropica-
mide (Mydriacyl) and 2.5% phenylephrine hydrochloride 
(Neosynephrine). 
Diabetic patients were classified into a cataract group and 
a control group without cataracts. We compared clinical data 
and ophthalmologic results between the cataract group and 
the control group. Risk factors for cataracts, including sex, 
age, the diabetic period, blood sugar in fasting, HbA1c, and 
presence of diabetic retinopathy, were evaluated. 
To analyze how the risk factors affected the occurrence of 
cataracts, chi-square analysis was used. To compare the 
difference of biochemical examination between the two 
groups, Student’s t-test was used. Multiple regression analysis 
was performed to investigate the relationship between various 
variables and the degree of lens opacity. A p-value<0.05 was 
considered significant. 
Results
The clinical characteristics of the patients are shown in 
Table 1. From a total of 850 diabetic patients, 425 patients 
(50.0%) had cataracts. The mean patient age was 58.07±
8.60 years old, the mean diabetic period was 10.03±7.17 
years, and the mean visual acuity was 0.69±0.27. 
Gender differed significantly between the cataract group 
and the controls (p=0.025). There were more females in the 
cataract group than the control group [370 (63.5%) vs. 238 
(56.0%); p=0.025]. The mean age in each group was not 
statistically different. The diabetic period was significantly 
longer in the cataract group than in the controls (13.03±6.96 
years vs. 7.03±6.04 years, p<0.001). The mean visual acuity 
was significantly worse in the cataract group than in the 
control group (0.58±0.27 vs. 0.79±0.22, p<0.001). More 
diabetic retinopathies were observed in the cataract group 
(321, 75.53%) than in the control group (159, 37.41%, 
p<0.001). 
Biochemical analyses of the two groups are shown in 
Table 2. Total cholesterol, triglyceride and LDL cholesterol 
were not different between the two groups. The level of 
blood sugar after fasting was higher in the cataract group 
than in the control group (178.88±81.23 mg/dl vs. 162.01± 
63.59 mg/dl; p=0.001). The level of HbA1c was higher in 
the cataract group than in the control group (8.28±1.89% vs. 
7.80±1.80%; p<0.001). The level of HDL-cholesterol was 
lower in the cataract group than the control group (44.32±
12.32 mg/dl vs. 46.12±11.37 mg/dl; p=0.026). The level of 
BUN was higher in the cataract group than the control group 
(18.68±11.88 mg/dl vs. 15.32±5.30 mg/dl; p<0.001). The 
level of creatinine was higher in the cataract group than the 
control group (1.13±0.83 mg/dl vs. 0.93±0.36 mg/dl; p< 
0.001).
As illustrated in Tables 2 and 3, risk factors, such as the 
diabetic period, fasting blood sugar, HbA1c, HDL-cholesterol, 
BUN, and creatinine, were different between the two groups. 
In multiple regression analysis (Table 3), the diabetic period 
(p<0.001) was the significant factor associated with cataracts 
in patients with diabetes mellitus. 
Discussion
Kini, et al
14 reported that senile cataracts caused visual loss 
in 22% of the general population. In Korea, cataracts were 
also reported as a main cause of the visual loss by 29.7% 
to 31.2% of the general population.
15,16 Persons with diabetes 
have been found to be at increased risk of visual impairment 
compared to non-diabetic persons.
17,18 
Since the study on the cataracts of diabetic patients in 
1798 by John Rollo, much research on cataracts has been 
reported. Cataracts occur at a younger age in diabetics than 
non-diabetics. The incidence of cataracts increases propor-
tionally with the degree and the period of the diabetes 
mellitus.
4-11 It is reported that most patients having lenticular 
opacity had diabetes mellitus for more than five years, and 
that various types of opacities of the lens were developed in 
64% of diabetic patients under treatment.
19 Caird et al
20 
reported that 10.7% of patients of senile cataract extraction 
had diabetes mellitus and that the cataract extraction rate in 
those cases was four to six times higher than the cases without 
diabetes mellitus. In these results, the cataract incidence rate SI  Kim,  et  al.  RISK  FACTORS  OF  CATARACTS  IN  DIABETES  MELLITUS
203
With  Cataract
(N=425)
Without  Cataract
(N=425) P-value
FBS  (mg/dl)*
HbA1c  (%)
Total  Cholesterol  (mg/dl) 
Triglyceride  (mg/dl)
HDL-cholesterol  (mg/dl)
LDL-cholesterol  (mg/dl)
BUN  (mg/dl)
Creatinine  (mg/dl)
178.88  ±  81.23
  8.28  ±  1.89
186.64  ±  41.00
  154.68  ±  112.09
  44.32  ±  12.32
111.39  ±  37.19
  18.68  ±  11.88
  1.13  ±  0.83
162.01  ±  63.59
  7.80  ±  1.80
186.78  ±  38.35
  150.83  ±  108.75
  46.12  ±  11.37
110.50  ±  33.96
15.32  ±  5.30
  0.93  ±  0.36
0.001
0.000
0.959
0.611
0.026
0.714
0.000
0.000
*F B S :  f a s t i n g  b l o o d  s u g a r .
Table 2. Biochemical  characteristics  of  subjects  studied
Standard  regression 
coefficient P-value
Duration
FBS*
HbA1c
HDL-cholesterol
BUN
Creatinine
0.389
0.064
0.064
-0.053
0.064
0.029
0.000
0.089
0.090
0.091
0.164
0.530
*F B S :  f a s t i n g  b l o o d  s u g a r .
Table 3. Results  of  multiple  regression  analysis  to  assess 
factors  relevant  to  the  cataracts
is higher in diabetes mellitus patients. In this study, the mean 
duration of diabetes mellitus in patients with cataracts was 
13.03±6.96 years.
Patterson reported that there was lenticular opacity when 
the blood sugar was more than 225 mg%.
21 The fasting blood 
sugar level was higher in the cataract group than in the 
control group (178.88±81.23 mg/dl vs. 162.01±63.59 mg/dl; 
p=0.001). However, in multiple regression tests, the level of 
blood sugar was not the significant factor associated with 
cataract for diabetes mellitus patients in this study. Previous 
studies reported that a direct relationship between glycated 
hemoglobin and cataracts was not found in the prevalence 
data; however, cataracts were associated with the duration of 
diabetes. It may be that the additional five-year duration was 
necessary to observe the effect of glycemia.
8,9,22 In this study, 
the level of HbA1c was higher in the cataract group than in 
the control group; however, in multiple regression tests it, 
too, was not a significant factor for cataract incidence with 
diabetes mellitus.
When considering the higher prevalence of diabetes 
mellitus in females than males, it follows that the incidence 
of diabetic cataracts would be higher in females.
5,19 The 
prevalence of diabetic cataracts was higher in women in this 
study. In terms of the relationship between cataracts and 
visual acuity, the worse the visual acuity deteriorated, the 
higher the incidence rate of cataract appeared. This is reason-
able because cataracts are the cause of visual loss. 
Previous studies reported that the retinopathy was an 
influential factor on the degree of cataract.
8,9 In diabetic 
patients, according to Kirby,
19 diabetic retinopathy was found 
in 40% of those without cataracts and 53% of those with 
cataracts. Our analysis shows that diabetic retinopathy appeared 
37.41% of those without cataracts and 75.53% of those with 
cataracts. Thus, it is predicted that many patients will have 
diabetic retinopathy when their cataracts have progressed. 
Moreover, since the frequency of patients with diabetic retino-
pathy was highest in the cataract group, we can say that the 
degree of impairment of internal organs due to diabetes 
mellitus is related to cataracts. 
In multiple regression analysis, we found that the duration 
of diabetes was the most important risk factor for diabetic 
cataracts, and the roles of fasting blood sugar level and 
HbA1c as risk factors were ambiguous. Because we used the 
fasting sugar level and other data that were checked on the 
day of the ophthalmic examination, these do not reflect the 
average values during the patients’ diabetic periods. So, 
except for the duration of diabetes, we could?not find the 
exact relationship between the risk factors associated with 
diabetes and cataract incidence. 
In conclusion, the duration of diabetes mellitus was the 
significant risk factor for cataracts. This study suggests that 
lenticular opacity incurred by a long duration of hypergly-
cemia is related to the incidence of cataracts, and that it 
would be possible to prevent the disease by controlling 
hyperglycemia. 
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